Coloplast announced it will acquire wound care product company Kerecis for $1.3 billion. The acquisition will give Coloplast an opportunity to “strategically strengthen [its] presence in the advanced ...
Coloplast is the market leader with an estimated 38% share; privately held competitors Hollister and ConvaTec roughly split the rest of the market. Although the ostomy market only grows in the ...
Ladies and gentlemen, welcome to the Coloplast A/S Q1 2024-'25 Earnings Release Conference Call. I'm Valentina, the Chorus Call operator. [Operator Instructions] The conference must not be recorded ...
Good morning to those of you here in the room, and also good morning to those of you joining us virtually today. On behalf of the Coloplast management team and on behalf of Investor Relations, I would ...
The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) Coloplast invites ...
Coloplast posted fiscal first-quarter results showing 6% organic top-line growth and a 26% reported operating margin, but foreign exchange was a headwind. Shares fell by roughly 8%. Based in Denmark, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results